The class of RIP Activators is diverse, covering chemicals that work through various molecular pathways. For instance, several RIP activators influence toll-like receptors (TLRs), which are critical for innate immune responses. Chemicals like Poly(I:C), Pam3CSK4, and LPS initiate signaling via different TLRs, resulting in RIP activation. Similarly, chemicals like Etoposide and Fas Ligand introduce cellular stress or damage signals, leading to an environment conducive for RIP activation. On the other hand, chemicals such as 5Z-7-Oxozeaenol act by inhibiting other proteins like TAK1, thus removing an inhibition layer and enabling RIP to perform its function. Despite their diverse mechanisms of action, all these chemicals share the common outcome of activating RIP, directly or indirectly. By doing so, they affect a range of cellular activities, from cell death to immune response and inflammation, demonstrating the pivotal role that RIP plays in cellular signaling pathways.
RIP (Receptor-Interacting Serine/Threonine Kinase 1) is a crucial cellular protein involved in multiple signaling pathways that regulate various biological processes, including necroptosis, a form of regulated cell death, and inflammation. RIP's function is highly regulated and influenced by several intracellular and extracellular signals. It plays an essential role in the assembly of diverse signaling complexes that manage these processes. Activation of RIP can be direct, where it gets phosphorylated, or indirect, where upstream events trigger its function. Chemical activators that affect RIP fall into a category called RIP Activators. These chemicals, such as Z-VAD-FMK, TNF-alpha, and SM-164, can activate RIP through different mechanisms, like inhibiting apoptosis or initiating specific signaling pathways. Some act upstream by affecting the molecules that ultimately influence RIP's action, while others directly target RIP or its immediate regulators.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that indirectly activates RIP by inhibiting apoptosis pathways. | ||||||
Polyinosinic acid - polycytidylic acid sodium salt, double-stranded | 42424-50-0 | sc-204854 sc-204854A | 10 mg 100 mg | $139.00 $663.00 | 2 | |
A synthetic analog of double-stranded RNA that activates RIP through TLR3. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
DNA topoisomerase II inhibitor that causes DNA damage, which in turn can lead to RIP activation. | ||||||
(5Z)-7-Oxozeaenol | 253863-19-3 | sc-202055 sc-202055A | 1 mg 5 mg | $157.00 $646.00 | 13 | |
An irreversible inhibitor of TAK1, which leads to activation of RIP. | ||||||